FDA in 2024 and Beyond: What Election-Year Changes Mean for Your Business

Loeb & Loeb LLP is proud to announce that Jim Czaban, Co-Chair, Life Sciences will be speaking during the FDA webinar "FDA in 2024 and Beyond: What Election-Year Changes Mean for Your Business" on June 13, 2024.

From the event website:
Prominent FDA-watchers and regulatory experts Wayne Pines, Jim Czaban, Betsy Foss-Campbell, Nimi Chhina and Sarah Blankstein explain it all. In a robust three-hour discussion led by Pines, they’ll look at recent developments in the drug and device environment and predict what we can expect from the FDA as we head into 2025. The outcome of the presidential election in November will impact the FDA, and companies need to plan now for all possible contingencies.

For more information, including how to register, please visit the event website.